Retinal Degenerative Diseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients with retinal degenerative diseases undergoing outpatient treatment at Osaka Medical and Pharmaceutical University Hospital. Diagnosis of retinitis pigmentosa and related disorders follows the Retinitis Pigmentosa Diagnosis and Treatment Guidelines. 2) Patients with retinal degenerative diseases who have previously visited this hospital since 2015. 3) No age restrictions apply.
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Retinal structure (retinal thickness, morphology of each layer) as determined by OCT (optical coherence tomography) examination | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual field, electroretinogram, fundus fluorescein angiography, fundus autofluorescence imaging, retinal and optic nerve blood flow, corneal findings, visual acuity, subjective symptoms, treatment methods, complications | — |
Countries
Japan
Contacts
Osaka Medical and Pharmaceutical University Department of Ophthalmology